5Yokoyama H, Wada T, Furuichi K. Immunomodulation effects and clinical evidence of apheresis in renal diseases. Ther Apher Dial,2003,7: 513.
6Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients, Arthritis Rheum, 1992,35 : 630.
7Stefanutti C, Vivenzio A, Di Giacomo S, et al. Cyclophospha mide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone. BioDrugs,2005,19:129.
8Palmer A, Cairns T, Dische F, et al. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption , prednisolone and cyclophosphamide. Nephrol Dial Transplant, 1991,6:536.